We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

194 hedge funds and large institutions have $149M invested in Editas Medicine in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

492% more call options, than puts

Call options by funds: $4.92M | Put options by funds: $830K

64% more capital invested

Capital invested by funds: $90.9M → $149M (+$58.4M)

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0% more funds holding

Funds holding: 194 → 194 (0)

1.47% less ownership

Funds ownership: 49.34% → 47.87% (-1.5%)

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Holders
194
Holders Change
–
Holders Change %
0%
% of All Funds
2.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
47
Reduced
57
Closed
23
Calls
$4.92M
Puts
$830K
Net Calls
+$4.09M
Net Calls Change
+$2.85M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.35M
2
N
Nuveen
North Carolina
+$3.19M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.97M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.71M
5
Walleye Capital
Walleye Capital
New York
+$1.1M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.3M
2
WP
Woodline Partners
California
-$1.86M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$1.32M
4
Morgan Stanley
Morgan Stanley
New York
-$929K
5
Citadel Advisors
Citadel Advisors
Florida
-$772K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFBT
151
Parkside Financial Bank & Trust
Missouri
$1.42K – – –
Zurich Cantonal Bank
152
Zurich Cantonal Bank
Switzerland
$1.25K – – –
FFO
153
Fortitude Family Office
Arizona
$1.13K – – –
RWM
154
Rialto Wealth Management
New York
$1.13K – – –
Northwestern Mutual Wealth Management
155
Northwestern Mutual Wealth Management
Wisconsin
$1.08K +$848 +304 +4,343%
ICM
156
Islay Capital Management
Texas
$1.04K – – –
NFSG
157
Newbridge Financial Services Group
Florida
$1.04K – – –
AG
158
AmeriFlex Group
Nevada
$1.04K +$419 +150 +100%
Daiwa Securities Group
159
Daiwa Securities Group
Japan
$1K – – –
LFG
160
Larson Financial Group
Missouri
$847 – – –
HPC
161
HM Payson & Co
Maine
$816 +$70 +25 +12%
WIM
162
Westside Investment Management
California
$695 – – –
RP
163
Raelipskie Partnership
Ontario, Canada
$694 – – –
SIS
164
Sound Income Strategies
Florida
$612 – – –
GWSA
165
Global Wealth Strategies & Associates
Colorado
$555 +$98 +35 +28%
RIL
166
Rothschild Investment LLC
Illinois
$521 -$419 -150 -50%
TWD
167
True Wealth Design
Ohio
$448 – – –
PMFA
168
Plante Moran Financial Advisors
Michigan
$347 – – –
VCM
169
Versant Capital Management
Arizona
$347 – – –
RFP
170
Root Financial Partners
California
$347 +$279 +100 New
ASN
171
Advisory Services Network
Georgia
$344 +$276 +99 New
SS
172
Sunbelt Securities
Texas
$312 +$251 +90 New
KFI
173
Key Financial Inc
Pennsylvania
$266 – – –
MBFW
174
Morton Brown Family Wealth
Pennsylvania
$226 – – –
TC
175
Truvestments Capital
Florida
$212 – – –
5 6
7
8 9

EDIT Hedge Fund Activity: Q3 2025 in Review

194 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2025, worth a combined $149M — up 64% from $90.9M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 23 closed out — a net gain of 1 holder — while 47 added to existing stakes and 57 trimmed.

The largest buyer was BlackRock, adding an estimated $3.35M. The largest seller was Millennium Management, cutting an estimated $4.3M.

  • 194 institutional investors held Editas Medicine (EDIT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $149M of Editas Medicine stock for Q3 2025, up 64% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2025 and 23 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2025 was BlackRock, an estimated $3.35M added.
  • The largest Editas Medicine seller in Q3 2025 was Millennium Management, an estimated $4.3M sold.

Based on aggregated 13F filings for Q3 2025.